Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis
Per Westermark, Gunilla T Westermark, Ole B Suhr, Svante Berg, Per Westermark, Gunilla T Westermark, Ole B Suhr, Svante Berg
Abstract
Background: Senile systemic amyloidosis (SSA) derived from wild-type transthyretin is a fairly common condition of old individuals, particularly men. The main presentation is by cardiac involvement, which can lead to severe restrictive cardiomyopathy. SSA is, however, a systemic disease, and amyloid deposits may appear in many other tissues but are thought to be without clinical symptoms outside the heart. Amyloid is a very common finding in cartilage and ligaments of elderly subjects, and transthyretin has been demonstrated in some deposits. Lumbar spinal stenosis is also a condition of usually elderly individuals in whom narrowing of the lumbar spinal canal leads to compression of nerves to the lower limbs.
Results: We questioned whether lumbar spinal stenosis sometimes could be a manifestation of undiagnosed SSA. In this first report we have studied the presence of amyloid in material obtained at surgery for spinal stenosis in 26 patients. Amyloid was found in 25 subjects. Transthyretin was demonstrated immunohistochemically in 5 out of 15 studied resected tissues. Four of the positive materials were analyzed with Western blot revealing both full-length transthyretin (TTR) and C-terminal TTR fragments, typically seen in SSA.
Conclusion: We conclude that lumbar spinal stenosis quite frequently may be a consequence of SSA and that further studies are warranted.
Keywords: apolipoprotein A-I; lumbar spinal stenosis; senile systemic amyloidosis; transthyretin.
Figures
References
- Katz JN, Harris MB. . N Engl J Med. 2008;358:818–25.
- Suri P, Rainville J, Kalichman L, Katz JN. . JAMA. 2010;304:2628–36.
- Sasaji T, Horaguchi K, Yamada N, Iwai K. . Ups J Med Sci. 2012;117:426–9.
- Ladefoged C, Christensen HE. . Acta Pathol Microbiol Scand A. 1980;88:55–8.
- Ladefoged C. . Ann Rheum Dis. 1986;45:668–72.
- Ladefoged C, Fedders O, Petersen OF. . Ann Rheum Dis. 1986;45:239–43.
- Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. . Amyloid. 2012;19:167–70.
- Westermark P. . Ups J Med Sci. 2011;116:81–9.
- Bardin T, Kuntz D, Zingraff J, Voisin M-C, Zelmar A, Lansaman J. . Arthritis Rheum. 1985;28:1052–8.
- Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, et al. . Biochem Biophys Res Commun. 1985;129:701–6.
- Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli F, Frangione B. . J Clin Invest. 1985;76:2425–9.
- Munoz-Gómez J, Bergadá-Barado E, Gómez-Pérez R, Llopart-Buisán E, Subías-Sobrevía E, Rotés-Querol J, et al. . Ann Rheum Dis. 1985;44:729–33.
- Heegaard NH. β2-Microglobulin: from physiology to amyloidosis. Amyloid. 2009;16:151–73.
- Giorgetti S, Rossi A, Mangione P, Raimondi S, Marini S, Stoppini M, et al. . Protein Sci. 2005;14:696–702.
- Kyle RA, Eilers SG, Linscheid RL, Gaffey TA. . Am J Clin Pathol. 1989;91:393–7.
- Yamamoto S, Kazama JJ, Narita I, Naiki H, Gejyo F. . Bone. 2009;45:S39–42.
- M’Bappé P, Grateau G. . Best Pract Res Clin Rheumatol. 2012;26:459–75.
- Ladefoged C. . Ann Rheum Dis. 1983;42:659–64.
- Foitschik T, Saeger W, Riebe M, Röcken C. . Amyloid. 2005;12:167–73.
- Niggemeyer O, Steinhagen J, Deuretzbacher G, Zustin J, Rüther W. . Arch Orthop Trauma Surg. 2011;131:637–43.
- Niggemeyer O, Steinhagen J, Fuerst M, Zustin J, Rüther W. . Rheumatol Int. 2012;32:2645–51.
- Mihara S, Kawai S, Gondo T, Ishihara T. . Histopathology. 1994;25:415–20.
- Gies U, Linke RP, Schachenmayr W. . Clin Neuropathol. 1996;15:54–9.
- D’Agostino AN, Mason MS, Quinn SF. . Clin Neuropathol. 1992;11:147–50.
- Pitkänen P, Westermark P, Cornwell GG., III . Am J Pathol. 1984;117:391–9.
- Westermark GT, Johnson KH, Westermark P. . Methods Enzymol. 1999;309:3–25.
- Bergström J, Gustavsson Å, Hellman U, Sletten K, Murphy CL, Weiss DT, et al. . J Pathol. 2005;206:224–32.
- Bergström J, Murphy CL, Weiss DT, Solomon A, Sletten K, Hellman U, et al. . Lab Invest. 2004;84:981–8.
- Ihse E, Ybo A, Suhr OB, Lindqvist P, Backman C, Westermark P. . J Pathol. 2008;216:253–61.
- Mucchiano GI, Häggqvist B, Sletten K, Westermark P. . J Pathol. 2001;193:270–5.
- Nyström SN, Westermark GT. . Amyloid. 2012;19:138–45.
- Ihse E, Suhr OB, Hellman U, Westermark P. . J Mol Med. 2011;89:171–80.
- Solomon A, Murphy CL, Kestler DP, Coriu D, Weiss DT, Makovitzky J, et al. . Arthritis Rheum. 2006;54:3545–50.
- Sueyoshi T, Ueda M, Jono H, Irie H, Sei A, Ide J, et al. . Hum Pathol. 2011;42:1259–64.
- Sueyoshi T, Ueda M, Sei A, Misumi Y, Oshima T, Yamashita T, et al. . Amyloid. 2011;18:165–8.
- Ihse E, Rapezzi C, Merlini G, Ando Y, Suhr OB, Ikeda S, et al. . Amyloid. 2013;20:142–50.
- Johansson B, Westermark P. . Int J Cardiol. 1991;32:83–92.
- Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. . Amyloid. 2003;10(Suppl 1):48–54.
- Sekijima Y, Uchiyama S, Tojo K, Sano K, Shimizu Y, Imaeda T, et al. . Hum Pathol. 2011;42:1785–91.
- Svendsen IH, Steensgaard-Hansen F, Nordvåg BY. . Eur Heart J. 1998;19:782–9.
Source: PubMed